vs
Side-by-side financial comparison of NSTS Bancorp, Inc. (NSTS) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Sensus Healthcare, Inc. is the larger business by last-quarter revenue ($4.9M vs $2.5M, roughly 2.0× NSTS Bancorp, Inc.). NSTS Bancorp, Inc. runs the higher net margin — 214.3% vs -64.1%, a 278.4% gap on every dollar of revenue. On growth, NSTS Bancorp, Inc. posted the faster year-over-year revenue change (3.0% vs -62.2%). NSTS Bancorp, Inc. produced more free cash flow last quarter ($3.9M vs $-2.4M). Over the past eight quarters, NSTS Bancorp, Inc.'s revenue compounded faster (11.7% CAGR vs -31.9%).
NSTS Bancorp, Inc. is a U.S.-based bank holding company. It offers a comprehensive suite of retail and commercial banking products and services, including deposit accounts, personal loans, commercial loans, and wealth management solutions, primarily serving individual consumers and small-to-medium enterprises in its regional operating areas.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
NSTS vs SRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5M | $4.9M |
| Net Profit | $135.0K | $-3.2M |
| Gross Margin | — | 38.4% |
| Operating Margin | — | -63.8% |
| Net Margin | 214.3% | -64.1% |
| Revenue YoY | 3.0% | -62.2% |
| Net Profit YoY | 393.5% | -304.9% |
| EPS (diluted) | — | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5M | $4.9M | ||
| Q3 25 | $2.5M | $6.9M | ||
| Q2 25 | $2.5M | $7.3M | ||
| Q1 25 | $2.2M | $8.3M | ||
| Q4 24 | $2.4M | $13.1M | ||
| Q3 24 | $2.3M | $8.8M | ||
| Q2 24 | $2.3M | $9.2M | ||
| Q1 24 | $2.0M | $10.7M |
| Q4 25 | $135.0K | $-3.2M | ||
| Q3 25 | $65.0K | $-943.0K | ||
| Q2 25 | $-258.0K | $-1.0M | ||
| Q1 25 | $-328.0K | $-2.6M | ||
| Q4 24 | $-46.0K | $1.5M | ||
| Q3 24 | $-171.0K | $1.2M | ||
| Q2 24 | $-326.0K | $1.6M | ||
| Q1 24 | $-246.0K | $2.3M |
| Q4 25 | — | 38.4% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 52.2% | ||
| Q4 24 | — | 54.4% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 58.7% | ||
| Q1 24 | — | 62.5% |
| Q4 25 | — | -63.8% | ||
| Q3 25 | 2.6% | -37.3% | ||
| Q2 25 | -10.1% | -26.6% | ||
| Q1 25 | -15.2% | -31.7% | ||
| Q4 24 | -71.9% | 13.2% | ||
| Q3 24 | -7.6% | 16.9% | ||
| Q2 24 | -14.2% | 21.5% | ||
| Q1 24 | -12.2% | 27.1% |
| Q4 25 | 214.3% | -64.1% | ||
| Q3 25 | 2.6% | -13.7% | ||
| Q2 25 | -10.1% | -14.2% | ||
| Q1 25 | -15.2% | -30.8% | ||
| Q4 24 | -71.9% | 11.8% | ||
| Q3 24 | -7.6% | 13.7% | ||
| Q2 24 | -14.2% | 17.4% | ||
| Q1 24 | -12.2% | 21.3% |
| Q4 25 | — | $-0.19 | ||
| Q3 25 | $0.01 | $-0.06 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.16 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-0.03 | $0.07 | ||
| Q2 24 | — | $0.10 | ||
| Q1 24 | — | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $80.0M | $48.1M |
| Total Assets | $266.6M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | $22.1M | ||
| Q3 25 | $34.1M | $24.5M | ||
| Q2 25 | $47.5M | $22.2M | ||
| Q1 25 | $57.5M | $19.1M | ||
| Q4 24 | $53.5M | $22.1M | ||
| Q3 24 | $34.6M | $22.6M | ||
| Q2 24 | $32.4M | $19.0M | ||
| Q1 24 | $36.4M | $14.7M |
| Q4 25 | $80.0M | $48.1M | ||
| Q3 25 | $78.9M | $51.2M | ||
| Q2 25 | $77.8M | $52.1M | ||
| Q1 25 | $77.5M | $53.0M | ||
| Q4 24 | $76.5M | $55.8M | ||
| Q3 24 | $78.4M | $54.1M | ||
| Q2 24 | $76.5M | $52.9M | ||
| Q1 24 | $77.0M | $51.2M |
| Q4 25 | $266.6M | $53.0M | ||
| Q3 25 | $269.8M | $58.3M | ||
| Q2 25 | $276.0M | $58.9M | ||
| Q1 25 | $282.7M | $60.2M | ||
| Q4 24 | $278.7M | $62.2M | ||
| Q3 24 | $268.4M | $59.9M | ||
| Q2 24 | $265.9M | $58.2M | ||
| Q1 24 | $265.6M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.1M | $-2.2M |
| Free Cash FlowOCF − Capex | $3.9M | $-2.4M |
| FCF MarginFCF / Revenue | 156.9% | -47.9% |
| Capex IntensityCapex / Revenue | 4.1% | 3.2% |
| Cash ConversionOCF / Net Profit | 30.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | $4.7M | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $-2.2M | ||
| Q3 25 | $2.9M | $2.3M | ||
| Q2 25 | $655.0K | $3.1M | ||
| Q1 25 | $-2.7M | $-2.7M | ||
| Q4 24 | $9.4M | $-827.0K | ||
| Q3 24 | $1.6M | $4.0M | ||
| Q2 24 | $-1.6M | $4.2M | ||
| Q1 24 | $92.0K | $-8.2M |
| Q4 25 | $3.9M | $-2.4M | ||
| Q3 25 | $2.9M | $2.3M | ||
| Q2 25 | $616.0K | $3.1M | ||
| Q1 25 | $-2.7M | $-2.7M | ||
| Q4 24 | $9.1M | $-1.1M | ||
| Q3 24 | $1.6M | $3.6M | ||
| Q2 24 | $-1.7M | $4.2M | ||
| Q1 24 | $76.0K | $-8.4M |
| Q4 25 | 156.9% | -47.9% | ||
| Q3 25 | 113.9% | 33.3% | ||
| Q2 25 | 24.2% | 42.2% | ||
| Q1 25 | -126.1% | -32.2% | ||
| Q4 24 | 373.1% | -8.6% | ||
| Q3 24 | 69.3% | 40.9% | ||
| Q2 24 | -76.4% | 45.8% | ||
| Q1 24 | 3.8% | -79.0% |
| Q4 25 | 4.1% | 3.2% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 1.5% | 0.4% | ||
| Q1 25 | 2.5% | 0.1% | ||
| Q4 24 | 13.1% | 2.3% | ||
| Q3 24 | 2.3% | 3.8% | ||
| Q2 24 | 5.1% | 0.0% | ||
| Q1 24 | 0.8% | 2.2% |
| Q4 25 | 30.01× | — | ||
| Q3 25 | 44.03× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NSTS
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
